Draig Therapeutics, a clinical-stage biopharmaceutical company developing transformative, best-in-class neuropsychiatric ...
We've talked plenty of times here about the infeasibility of launching a mirror big enough to directly image exoplanets using ...
Researchers created a programmable thermal material that steers heat and retains its state without power, a breakthrough that ...
A black hole energy extraction experiment has brought one of astrophysics’ most remarkable predictions into the laboratory. Researchers created a stationary electronic device that amplifies ...
NASA is ramping up its lunar ambitions by awarding nearly $600 million for four commercial Moon landings planned for late ...
Invited Speakers. The following invited speakers have already accepted our invitation: Francesco Ancilotto, University of Padova: "Vortices in He-4 nanodroplets from Density Funct ...
Regulatory review is supported by SUCCESSOR-2, a seamless, randomized, open-label phase 3 study selecting mezigdomide 1.0 mg daily for stage 2. Efficacy favored MeziKd with consistent subgroup PFS ...